AIM: To replicate the genome-wide associations of the antihypertensive effects of bisoprolol and losartan in GENRES, using the Finnish patients of LIFE study. PATIENTS & METHODS: We analyzed association of four SNPs with atenolol and three SNPs with losartan response in 927 Finnish LIFE patients (467 foratenolol and 460 for losartan). RESULTS: rs2514036, a variation at a transcription start site of ACY3, was associated with blood pressure response to atenolol in men in LIFE. Response to bisoprolol was correlated to baseline plasma levels of N-acetylphenylalanine and phenylalanine (ACY3 substrate and end product, respectively) in GENRES study. NPHS1 variation rs3814995 was associated with losartan effect in LIFE. CONCLUSION: We provide support for two pharmacogenomic markers for beta-blockers and angiotensin receptor antagonists.
RCT Entities:
AIM: To replicate the genome-wide associations of the antihypertensive effects of bisoprolol and losartan in GENRES, using the Finnish patients of LIFE study. PATIENTS & METHODS: We analyzed association of four SNPs with atenolol and three SNPs with losartan response in 927 Finnish LIFE patients (467 for atenolol and 460 for losartan). RESULTS:rs2514036, a variation at a transcription start site of ACY3, was associated with blood pressure response to atenolol in men in LIFE. Response to bisoprolol was correlated to baseline plasma levels of N-acetylphenylalanine and phenylalanine (ACY3 substrate and end product, respectively) in GENRES study. NPHS1 variation rs3814995 was associated with losartan effect in LIFE. CONCLUSION: We provide support for two pharmacogenomic markers for beta-blockers and angiotensin receptor antagonists.
Authors: Michael T Eadon; Judith Maddatu; Sharon M Moe; Arjun D Sinha; Ricardo Melo Ferreira; Brent W Miller; S Jawad Sher; Jing Su; Victoria M Pratt; Arlene B Chapman; Todd C Skaar; Ranjani N Moorthi Journal: Kidney360 Date: 2022-02-24
Authors: Marja-Liisa Nuotio; Heini Sánez Tähtisalo; Alexandra Lahtinen; Kati Donner; Frej Fyhrquist; Markus Perola; Kimmo K Kontula; Timo P Hiltunen Journal: Epigenetics Date: 2022-02-25 Impact factor: 4.861
Authors: Kimberly S Collins; Victoria M Pratt; Wesley M Stansberry; Elizabeth B Medeiros; Karthik Kannegolla; Marelize Swart; Todd C Skaar; Arlene B Chapman; Brian S Decker; Ranjani N Moorthi; Michael T Eadon Journal: Pharmacogenet Genomics Date: 2019-01 Impact factor: 2.089
Authors: Timo P Hiltunen; Jenni M Rimpelä; Robert P Mohney; Steven M Stirdivant; Kimmo K Kontula Journal: PLoS One Date: 2017-11-09 Impact factor: 3.240
Authors: Jenni M Rimpelä; Ilkka H Pörsti; Antti Jula; Terho Lehtimäki; Teemu J Niiranen; Lasse Oikarinen; Kimmo Porthan; Antti Tikkakoski; Juha Virolainen; Kimmo K Kontula; Timo P Hiltunen Journal: BMC Med Genet Date: 2018-07-04 Impact factor: 2.103
Authors: Sonal Singh; Helen R Warren; Timo P Hiltunen; Caitrin W McDonough; Nihal El Rouby; Erika Salvi; Zhiying Wang; Tatiana Garofalidou; Frej Fyhrquist; Kimmo K Kontula; Valeria Glorioso; Roberta Zaninello; Nicola Glorioso; Carl J Pepine; Patricia B Munroe; Stephan T Turner; Arlene B Chapman; Eric Boerwinkle; Julie A Johnson; Yan Gong; Rhonda M Cooper-DeHoff Journal: J Am Heart Assoc Date: 2019-08-19 Impact factor: 5.501